BioTek announces the launch of the Epoch™ Multi-Volume Spectrophotometer System for monochromator based absorbance measurements in volumes as low as 2 µL. The system includes the Epoch Microplate Spectrophotometer and the unique Take3™ Multi-Volume Plate, controlled via Gen5™ software. These two new products combine to provide a high value solution for the life science laboratory that has multiple users, multiple assays, and the need to preserve precious nucleic acid and protein samples by using very small volumes for quantification. No other system can provide researchers with the combination of versatility and affordability found in the Epoch Multi-Volume Spectrophotometer System.
Introducing a New Epoch in Spectrophotometer Technology
With its wavelength range of 200 nm to 999 nm, the Epoch Microplate Spectrophotometer provides outstanding performance in nucleic acid and protein quantification, wavelength scanning, end point, kinetic and well area scanning in 6- to 384-well microplates. The Take3 plate allows users to measure up to sixteen 2 µL samples, two BioCells or a standard cuvette. The Take3 interface in Gen5 software makes low volume nucleic acid quantification fast and easy with its pre-programmed protocols and data output.
Additional information on the Epoch Multi-Volume Spectrophotometer System components may be found at www.biotek.com, and on-site demonstrations are available through BioTek’s global network of microplate specialists.
BioTek Instruments, Inc., headquartered in Winooski, VT, USA, is a worldwide leader in the design, manufacture, and sale of microplate instrumentation and software. BioTek instrumentation is used to aid in the advancement of life science research, facilitate the drug discovery process and to enable cost-effective quantification of disease relevant molecules in the clinic.
Company websiteBioTek Instruments, Inc.